Alastair MacDonald | Vice President, Medical Affairs
Sciensus

Alastair has 30+ years of experience in the biopharmaceutical development of pre- and post-approval drugs. From 2001-2017, Alastair held a variety of senior positions at AstraZeneca, including laterally as Global Head of Delivery for Real World Evidence (RWE). Here, he had responsibility for the delivery of both pre and post approval evidence generation programmes supporting key assets that have gone on to become world class products. From 2017-2024 he worked at Syneos Health, a world leading Product Development Organization. As a Senior Vice President of Strategic Alliances, he assisted key clients to clinically develop and successfully commercialize assets, particularly through the generation of Real-World Evidence  Now at Sciensus, Alastair successfully helps patients across Europe gain access to treatments and candidate drugs.Enabled by this primary source patient access, data is captured through an innovative digital platform. These real-world insights drive better health outcomes including adherence and patient engagement.